From 1968 to 2020, people experienced a remarkable increase in life expectancy, from 70 to 78 years. Much of that was due to ...

Findings showed MenABCWY met the primary endpoint demonstrating noninferiority to 2 doses of Bexsero and 1 dose of Menveo for all 5 Neisseria meningitidis serogroups (A, B, C, W and Y).

GSK’s total sales increased 10% in the first quarter of 2024 compared to the same period last year, thanks in large part to ...

The vaccine candidate demonstrated non-inferiority in primary endpoints for five Neisseria meningitidis serogroups (A, B, C, W, and Y) compared to two doses of Bexsero (meningococcal group B ...

At the same time, the results from the trial will be used as a confirmatory study to seek a full license for Bexsero, which was given accelerated approval by the FDA in 2015. In the meantime ...

GSK’s trial, which involved two doses given six months apart to approximately 3,650 participants aged 10-25, will serve a dual purpose as a confirmatory study that should convert Bexsero’s ...

Meningococcal B (Separate from Meningitis) 2 doses of the same brand (Bexsero or Trumenba), if 23 or younger. Tuberculosis Clearance International students must have a QFT (Quantiferon blood test) or ...

Acceptable versions: Menactra, Menveo, or MCV4. Non-acceptable versions: Bexsero or Trumenba (MenB) or HIB Meningitis. Tuberculosis (TB) Blood Test result / QuantiFERON. This test must be completed no ...

GSK plc GSK reported core earnings of $1.09 per American depositary share (“ADS”) in first- quarter 2024, beating the Zacks ...

which includes Bexsero and Trumenba. The CDC recommends the MenACWY vaccine for first-year college students living in residence halls. This is the vaccine we require. We offer the MenACWY and MenB ...

Key growth drivers were geographical expansion and market growth for Shingrix, and inclusion in National Immunization Programs for Bexsero. Pandemic vaccines sales reflected GSK’s share of 2023 ...